Rhythm Pharmaceuticals, Inc. RYTM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$202.68M-3.1% | -$196.54M-2.2% | -$192.33M-5.0% | -$183.1M-8.5% | -$168.73M+35.3% | ||
| $77.06M+15.3% | $66.82M+15.0% | $58.11M+15.5% | $50.3M+12.3% | $44.78M+12.8% | ||
| —— | —— | —— | —— | —— | ||
| $10.46M+31.6% | $7.95M+1.0% | $7.87M+7.5% | $7.32M-32.3% | $10.81M+6.8% | ||
| $19.91M-9.1% | $21.89M-38.9% | $35.82M+10.9% | $32.31M+65.4% | $19.54M-10.9% | ||
| $64K-83.9% | $397K+108% | -$5.07M+54.8% | -$11.22M-63.8% | -$6.85M+13.8% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | -$1.29M— | ||
| -$119.51M-3.3% | -$115.68M-6.0% | -$109.13M-1.3% | -$107.72M+5.1% | -$113.49M+0.3% | ||
| $357.35M+2.5% | $348.67M-11.7% | $394.7M+50.4% | $262.48M— | —— | ||
| $293.39M+16.2% | $252.47M-12.4% | $288.36M+6.0% | $272.16M+9.3% | $248.92M-4.5% | ||
| —— | —— | —— | —— | —— | ||
| $19.59M-1.6% | $19.92M+8.7% | $18.33M+13.9% | $16.09M+9.2% | $14.73M+14.2% | ||
| —— | —— | —— | —— | $66.83M+70.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $219.5M+14.8% | ||
| $537K+517% | $87K-91.3% | $1M+975% | $93K+31.0% | $71K+3,450% | ||
| -$45.9M-24.5% | -$36.85M-873% | $4.77M+118% | -$26.02M-149% | $52.67M+80.4% | ||
| $431K+0.7% | $428K-0.5% | $430K-0.9% | $434K+8.8% | $399K-0.3% | ||
| $1.21M-9.8% | $1.34M-7.7% | $1.45M-5.3% | $1.53M-0.7% | $1.54M-1.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$1.29M— | ||
| -$660K+27.5% | -$910K-1.1% | -$900K+14.3% | -$1.05M-23.5% | -$850K+40.1% | ||
| —— | —— | —— | $15.82M+151% | $6.31M+14.2% | ||
| -$6.17M+5.4% | -$6.52M+4.2% | -$6.8M+10.2% | -$7.57M+11.8% | -$8.58M-5.1% | ||
| $19.75M-4.0% | $20.58M-3.9% | $21.42M-2.3% | $21.92M-0.4% | $22M+6.8% | ||
| —— | —— | —— | —— | $0— | ||
| $357.35M+2.5% | $348.67M-11.7% | $394.7M+50.4% | $262.48M— | —— | ||
| $293.39M+16.2% | $252.47M-12.4% | $288.36M+6.0% | $272.16M+9.3% | $248.92M-4.5% | ||
| —— | $188.66M+33.3% | $141.49M+50.0% | $94.33M+100% | $47.16M— | ||
| $1.98M+25.1% | $1.58M— | —— | —— | —— | ||
| $537K+517% | $87K-91.3% | $1M+975% | $93K+31.0% | $71K+3,450% | ||
| —— | $0-100% | $4.68M-50.0% | $9.36M-33.3% | $14.04M-25.0% | ||
| $5.16M-4.1% | $5.38M-0.1% | $5.39M+0.9% | $5.34M+0.9% | $5.29M+33.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rhythm Pharmaceuticals, Inc. generate?
- Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
- Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
